llise is a Founder and the Chief Medical Officer of Arvelle. Prior to that she was Chief Medical Officer at Axovant. She has 15 years of experience leading clinical development and medical affairs programs across multiple therapeutic areas including neurological and psychiatric disorders. Ilise has successfully managed clinical development and strategy, regulatory authority approval, and post-marketing activities.
Previously, she was Vice President, Clinical Development and Medical Affairs, at FORUM Pharmaceuticals. Ilise also previously led a multi-therapeutic Medical Affairs group and development teams at Pfizer. She is a trained psychiatrist and has worked in academic research and clinical practice. Prior to entering the pharmaceutical industry, she was an Assistant Professor of Clinical Research at Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute. Ilise received an M.D. from Yale University, an M.Phil. from the University of Cambridge, and an A.B. from Brown University.
She completed a research fellowship in molecular biology at Yale University and the University of Cambridge and completed her internship and residency in psychiatry as well as a four-year post-doctoral fellowship in molecular neuroimaging at Columbia University College of Physicians and Surgeons.